1. Home
  2. PFE
  3. PFE News

Latest Pfizer Inc. (PFE) News on August 8, 2025

PFE

MT Newswires

6 hours ago

GSK to Receive $370 Million From CureVac, BioNTech Patent Dispute Settlement

GSK to Receive $370 Million in U.S. Patent Litigation Settlement
PFE

The Wall Street Journal

10 hours ago

GSK to Receive $370 Million in U.S. Patent Litigation Settlement

Pfizer (PFE) Releases Financial Results for Q2 2025
PFE

Insider Monkey

14 hours ago

Pfizer (PFE) Releases Financial Results for Q2 2025

PFE

Morningstar Research

20 hours ago

Analyst Report: Viatris Inc.

Healthcare Stocks Have Been Beaten Up. The Case for Buying Now.
PFE

Barrons.com

a day ago

Healthcare Stocks Have Been Beaten Up. The Case for Buying Now.

Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma
PFE

GlobeNewswire

a day ago

Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma

United States Vaccines Market Insights and Forecasts 2024 & 2025-2033 | Rising Infectious Disease Burden, Robust Funding and Regulatory Support Accelerate Innovation
PFE

GlobeNewswire

a day ago

United States Vaccines Market Insights and Forecasts 2024 & 2025-2033 | Rising Infectious Disease Burden, Robust Funding and Regulatory Support Accelerate Innovation

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda
PFE

GlobeNewswire

a day ago

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda

RFK Jr’s mRNA funding halt signals “shift in US public health”
PFE

Pharmaceutical Technology

a day ago

RFK Jr’s mRNA funding halt signals “shift in US public health”

This 7% Yielding Stock Just Raised Its Profit Forecast. Is It Time to Buy?
PFE

Motley Fool

a day ago

This 7% Yielding Stock Just Raised Its Profit Forecast. Is It Time to Buy?

RFK Jr. Ordered the HHS to Stop Funding mRNA Vaccine Development. The Edict Hit a Biotech Working on an Unrelated Treatment.
PFE

Barrons.com

2 days ago

RFK Jr. Ordered the HHS to Stop Funding mRNA Vaccine Development. The Edict Hit a Biotech Working on an Unrelated Treatment.

Chai Discovery Announces $70 million Series A To Transform Molecular Design
PFE

Business Wire

2 days ago

Chai Discovery Announces $70 million Series A To Transform Molecular Design

Pfizer CEO says has spoken with Trump, in ‘productive’ talks with government
PFE

TipRanks

2 days ago

Pfizer CEO says has spoken with Trump, in ‘productive’ talks with government

PFE

MT Newswires

2 days ago

BofA Securities Raises Price Target on Pfizer to $28 From $27, Maintains Neutral Rating

Pfizer Second Quarter 2025 Earnings: Beats Expectations
PFE

Simply Wall St.

2 days ago

Pfizer Second Quarter 2025 Earnings: Beats Expectations

1 Reason to Buy Pfizer (PFE) Stock
PFE

Motley Fool

2 days ago

1 Reason to Buy Pfizer (PFE) Stock

PFE

MT Newswires

2 days ago

US Health Department Ending Federal mRNA Vaccine Development

PFE

MT Newswires

2 days ago

Morgan Stanley Adjusts Price Target on Pfizer to $33 From $32, Maintains Equalweight Rating

PFE

MT Newswires

2 days ago

Citigroup Adjusts Price Target on Pfizer to $26 From $25, Maintains Neutral Rating

PFE

MT Newswires

2 days ago

Wolfe Adjusts Price Target on Pfizer to $25 From $23, Maintains Underperform Rating

Cancer Antibody Drug Conjugates Market Research 2025-2031 | Pfizer, AstraZeneca, and Biotechs Like Miracogen Advance Cancer ADCs with Strategic Acquisitions and Innovative Pipelines
PFE

GlobeNewswire

2 days ago

Cancer Antibody Drug Conjugates Market Research 2025-2031 | Pfizer, AstraZeneca, and Biotechs Like Miracogen Advance Cancer ADCs with Strategic Acquisitions and Innovative Pipelines

Pfizer Q2 Earnings Loom--Should You Buy, Hold, or Sell?
PFE

GuruFocus.com

3 days ago

Pfizer Q2 Earnings Loom--Should You Buy, Hold, or Sell?

PFE

MT Newswires

3 days ago

Sector Update: Health Care Stocks Lean Lower Premarket Tuesday

PFE

MT Newswires

3 days ago

Corporate Earnings Buoy US Equity Futures Pre-Bell

Pfizer Smashes Earnings Forecasts And Raises Outlook; Shares Jump
PFE

Investor's Business Daily

3 days ago

Pfizer Smashes Earnings Forecasts And Raises Outlook; Shares Jump

PFE

MT Newswires

3 days ago

Earnings in Focus as US Equity Futures Post Narrow Gains Pre-Bell

Earnings live: Palantir stock pops, Pfizer beats, Caterpillar warns of tariff impact
PFE

Yahoo Finance

3 days ago

Earnings live: Palantir stock pops, Pfizer beats, Caterpillar warns of tariff impact

Pfizer, Caterpillar and Marriott: Market Movers
PFE

Yahoo Finance Video

3 days ago

Pfizer, Caterpillar and Marriott: Market Movers

Pfizer (PFE) Surpasses Q2 Earnings and Revenue Estimates
PFE

Zacks

3 days ago

Pfizer (PFE) Surpasses Q2 Earnings and Revenue Estimates

Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
PFE

CNW Group

4 days ago

Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas

BioNTech Stock Rises as Drugmaker Beats Earnings Expectations.
PFE

Barrons.com

4 days ago

BioNTech Stock Rises as Drugmaker Beats Earnings Expectations.

How To Earn $500 A Month From Pfizer Stock Ahead Of Q2 Earnings
PFE

Benzinga

4 days ago

How To Earn $500 A Month From Pfizer Stock Ahead Of Q2 Earnings

PFE

MT Newswires

4 days ago

Central Bank Outlook Lifts Wall Street Pre-Bell; Asia, Europe Up

PFE

Argus Research

4 days ago

Market Digest: TEVA, AMT, HOG, IEX, LMT, SPGI, PWR, XYL, LEA

These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Reasonably Well
PFE

Simply Wall St.

4 days ago

These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Reasonably Well

Option Volatility And Earnings Report For Aug 4 - 8
PFE

Barchart

4 days ago

Option Volatility And Earnings Report For Aug 4 - 8

BioNTech's Q2 revenues double on higher COVID vaccine sales
PFE

Reuters

4 days ago

BioNTech's Q2 revenues double on higher COVID vaccine sales

The 3 Things That Matter for Pfizer Now
PFE

Motley Fool

5 days ago

The 3 Things That Matter for Pfizer Now

Job market concerns take center stage as earnings season rolls on: What to watch this week
PFE

Yahoo Finance

5 days ago

Job market concerns take center stage as earnings season rolls on: What to watch this week

What To Expect in Markets This Week: Earnings From Palantir, AMD, McDonald’s and More
PFE

Investopedia

5 days ago

What To Expect in Markets This Week: Earnings From Palantir, AMD, McDonald’s and More

Trump tariffs trigger fear and loathing in ‘Viagra village’
PFE

The Telegraph

7 days ago

Trump tariffs trigger fear and loathing in ‘Viagra village’

Earnings, Fed commentary, consumer credit: What to Watch
PFE

Yahoo Finance Video

7 days ago

Earnings, Fed commentary, consumer credit: What to Watch

McDonald’s, Palantir, Novo Nordisk Earnings: What to Watch Next Week
PFE

The Wall Street Journal

7 days ago

McDonald’s, Palantir, Novo Nordisk Earnings: What to Watch Next Week

MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View
PFE

Zacks

7 days ago

MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View

Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 Earnings
PFE

Zacks

7 days ago

Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 Earnings

3 Dividend Healthcare Stocks to Buy Hand Over Fist Before They Double
PFE

Motley Fool

7 days ago

3 Dividend Healthcare Stocks to Buy Hand Over Fist Before They Double

PFE

MT Newswires

7 days ago

Update: Moderna Wins UK Patent Dispute Against Pfizer, BioNTech

Moderna's Key Patent Win Overshadowed By Gloomy Outlook
PFE

Benzinga

7 days ago

Moderna's Key Patent Win Overshadowed By Gloomy Outlook

PFE

MT Newswires

7 days ago

Moderna Wins UK Patent Dispute Against Pfizer, BioNTech

PFE

MT Newswires

7 days ago

Pharma Stocks Fall Pre-Bell After Trump's Letters to Companies Over Drug Pricing

Fibromyalgia Market Analysis Report 2025-2035 | Key Players Drive Competition in Expanding Treatment Options
PFE

GlobeNewswire

7 days ago

Fibromyalgia Market Analysis Report 2025-2035 | Key Players Drive Competition in Expanding Treatment Options

Testicular Cancer Market Analysis and Forecast Report 2025-2035 | Emerging Trends Highlight Shift Towards Immunotherapy in Testicular Cancer
PFE

GlobeNewswire

7 days ago

Testicular Cancer Market Analysis and Forecast Report 2025-2035 | Emerging Trends Highlight Shift Towards Immunotherapy in Testicular Cancer

Tenosynovitis Market Research Report 2025-2035 | Rising Demand for Tenosynovitis Treatment Amid Increasing Rheumatoid Arthritis Cases
PFE

GlobeNewswire

7 days ago

Tenosynovitis Market Research Report 2025-2035 | Rising Demand for Tenosynovitis Treatment Amid Increasing Rheumatoid Arthritis Cases

Trump Demands Pharma Companies to Lower US Prices
PFE

Bloomberg

7 days ago

Trump Demands Pharma Companies to Lower US Prices

Trump doubles down on Most Favored Nation plan to target drug prices
PFE

Pharmaceutical Technology

8 days ago

Trump doubles down on Most Favored Nation plan to target drug prices

Marengo Therapeutics Bolsters Advisory Strength with Appointment of Dr. Mikael Dolsten to its Board of Directors and Dr. Josep Tabernero to its Scientific Advisory Board
PFE

PR Newswire

8 days ago

Marengo Therapeutics Bolsters Advisory Strength with Appointment of Dr. Mikael Dolsten to its Board of Directors and Dr. Josep Tabernero to its Scientific Advisory Board

Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas
PFE

GlobeNewswire

8 days ago

Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas

Systemic Lupus Erythematosus Clinical Trials Market Landscape Report 2025 Featuring GSK, BMS, AstraZeneca, Thermo Fisher Scientific, ICON, IQVIA, Parexel, Laboratory Corp of America, Novartis, Pfizer
PFE

GlobeNewswire

8 days ago

Systemic Lupus Erythematosus Clinical Trials Market Landscape Report 2025 Featuring GSK, BMS, AstraZeneca, Thermo Fisher Scientific, ICON, IQVIA, Parexel, Laboratory Corp of America, Novartis, Pfizer

Mycosis Fungoides Clinical Trials Market Landscape Report 2025 Featuring Pfizer, Bristol-Myers Squibb, Kirin, Takeda, Johnson & Johnson, Merck, Soligenix, Eisai, Novartis, ICON
PFE

GlobeNewswire

8 days ago

Mycosis Fungoides Clinical Trials Market Landscape Report 2025 Featuring Pfizer, Bristol-Myers Squibb, Kirin, Takeda, Johnson & Johnson, Merck, Soligenix, Eisai, Novartis, ICON

Glaucoma Global Clinical Trials Market Landscape Report 2025 Featuring Alcon, AbbVie, Santen Pharmaceutical, Pfizer, Kowa, Viatris, Merck, Novartis, Senju Pharmaceutical, Bausch Health
PFE

GlobeNewswire

8 days ago

Glaucoma Global Clinical Trials Market Landscape Report 2025 Featuring Alcon, AbbVie, Santen Pharmaceutical, Pfizer, Kowa, Viatris, Merck, Novartis, Senju Pharmaceutical, Bausch Health

Where Will Pfizer (PFE) Be in 5 Years?
PFE

Motley Fool

8 days ago

Where Will Pfizer (PFE) Be in 5 Years?

Ireland awakens to the risk of relying on US investment
PFE

Financial Times

9 days ago

Ireland awakens to the risk of relying on US investment

Bank of America Securities Maintains a Hold on Pfizer (PFE)
PFE

Insider Monkey

9 days ago

Bank of America Securities Maintains a Hold on Pfizer (PFE)

Time to Go Short on Pfizer (PFE)?
PFE

Insider Monkey

9 days ago

Time to Go Short on Pfizer (PFE)?

Australia Anti-Venom Market Analysis Report 2025-2033 Featuring BSV, Boehringer Ingelheim, Boston Scientific, CSL, Merck, Pfizer, Haffkine Bio-Pharmaceutical
PFE

GlobeNewswire

9 days ago

Australia Anti-Venom Market Analysis Report 2025-2033 Featuring BSV, Boehringer Ingelheim, Boston Scientific, CSL, Merck, Pfizer, Haffkine Bio-Pharmaceutical

Pfizer Stock Is a Value Play Ahead of Earnings - Investors Can Short PFE Puts for Income
PFE

Barchart

10 days ago

Pfizer Stock Is a Value Play Ahead of Earnings - Investors Can Short PFE Puts for Income

Merck Earnings Beat Analyst Estimates. Why the Stock Is Dropping.
PFE

Barrons.com

10 days ago

Merck Earnings Beat Analyst Estimates. Why the Stock Is Dropping.

Chondrosarcoma Market Report 2025-2035: Increased Research on Rare Skeletal Tumors and IDH1/2 Mutation-targeted Therapies
PFE

GlobeNewswire

10 days ago

Chondrosarcoma Market Report 2025-2035: Increased Research on Rare Skeletal Tumors and IDH1/2 Mutation-targeted Therapies

Pfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?
PFE

Zacks

10 days ago

Pfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?

Pfizer Stock: Analyst Estimates & Ratings
PFE

Barchart

10 days ago

Pfizer Stock: Analyst Estimates & Ratings

Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock?
PFE

Zacks

10 days ago

Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock?

BenchSci Expands Board of Directors with Appointment of Dr. Mikael Dolsten
PFE

Business Wire

10 days ago

BenchSci Expands Board of Directors with Appointment of Dr. Mikael Dolsten

Merck (MRK) Tops Q2 Earnings Estimates
PFE

Zacks

10 days ago

Merck (MRK) Tops Q2 Earnings Estimates

North America Clinical Trials Market Forecast and Company Analysis Report 2025-2033 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, and Medpace
PFE

GlobeNewswire

10 days ago

North America Clinical Trials Market Forecast and Company Analysis Report 2025-2033 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, and Medpace

Jim Cramer on Pfizer: “We are Still on the Verge of Finding Out What the Seagen Acquisition Does”
PFE

Insider Monkey

11 days ago

Jim Cramer on Pfizer: “We are Still on the Verge of Finding Out What the Seagen Acquisition Does”

Josh Brown on Pfizer (PFE): ‘I Was Dead Wrong, There’s No Turnaround’
PFE

Insider Monkey

11 days ago

Josh Brown on Pfizer (PFE): ‘I Was Dead Wrong, There’s No Turnaround’

Healthcare Earnings Are Coming. 4 Big Questions for CVS, Humana, Merck, UnitedHealth, and More.
PFE

Barrons.com

11 days ago

Healthcare Earnings Are Coming. 4 Big Questions for CVS, Humana, Merck, UnitedHealth, and More.

Ireland's 'economic miracle' at risk from tariffs
PFE

AFP

11 days ago

Ireland's 'economic miracle' at risk from tariffs

3 Surprisingly Underrated Stocks to Buy Right Now
PFE

Motley Fool

11 days ago

3 Surprisingly Underrated Stocks to Buy Right Now

Morgan Stanley Maintains a Hold on Pfizer (PFE)
PFE

Insider Monkey

11 days ago

Morgan Stanley Maintains a Hold on Pfizer (PFE)

Pfizer Inc. (PFE) Finalizes Global Licensing Agreement with 3sbio, Inc.
PFE

Insider Monkey

12 days ago

Pfizer Inc. (PFE) Finalizes Global Licensing Agreement with 3sbio, Inc.

Pfizer (PFE) Receives CHMP Recommendation For Adapted COVID-19 Vaccine COMIRNATY
PFE

Simply Wall St.

13 days ago

Pfizer (PFE) Receives CHMP Recommendation For Adapted COVID-19 Vaccine COMIRNATY

Metastatic Hormone Refractory Prostate Cancer Pipeline Market Research Report 2025 | In-depth Analysis of 180+ Companies and Over 200 Drugs in Development
PFE

GlobeNewswire

14 days ago

Metastatic Hormone Refractory Prostate Cancer Pipeline Market Research Report 2025 | In-depth Analysis of 180+ Companies and Over 200 Drugs in Development

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
PFE

Zacks

14 days ago

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

Pfizer and 3SBio conclude licensing deal for SSGJ-707
PFE

Pharmaceutical Technology

14 days ago

Pfizer and 3SBio conclude licensing deal for SSGJ-707

PFE

MT Newswires

14 days ago

Pfizer, BioNTech's Updated COVID-19 Vaccine Recommended for EU Approval

Post-Operative Nausea and Vomiting Market Report 2025: Surge in Surgical Procedures Fuels $2.97 Billion Growth in PONV Market by 2029
PFE

GlobeNewswire

14 days ago

Post-Operative Nausea and Vomiting Market Report 2025: Surge in Surgical Procedures Fuels $2.97 Billion Growth in PONV Market by 2029

GM Is Loading Up on Its Own Shares. Investors Should Follow Suit.
PFE

Barrons.com

14 days ago

GM Is Loading Up on Its Own Shares. Investors Should Follow Suit.

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union
PFE

GlobeNewswire

14 days ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Zoetis (ZTS): Buy, Sell, or Hold Post Q1 Earnings?
PFE

StockStory

15 days ago

Zoetis (ZTS): Buy, Sell, or Hold Post Q1 Earnings?

Truist Sees Upside in BridgeBio Pharma’s (BBIO) ATTR-CM Strategy
PFE

Insider Monkey

15 days ago

Truist Sees Upside in BridgeBio Pharma’s (BBIO) ATTR-CM Strategy

AI Investment Is Already Huge. Google, Trump Show Much More Is Coming.
PFE

Barrons.com

15 days ago

AI Investment Is Already Huge. Google, Trump Show Much More Is Coming.

Pfizer (PFE) Faces Legal Challenges Over Depo-Provera's Increased Brain Tumor Risk
PFE

Simply Wall St.

15 days ago

Pfizer (PFE) Faces Legal Challenges Over Depo-Provera's Increased Brain Tumor Risk

Selective Estrogen Receptor Degrader (SERDs) Market Research Report 2025-2030 Featuring AstraZeneca, Eli Lilly, EnhancedBio, Olema Oncology, Radius Therapeutics, and Roche
PFE

GlobeNewswire

15 days ago

Selective Estrogen Receptor Degrader (SERDs) Market Research Report 2025-2030 Featuring AstraZeneca, Eli Lilly, EnhancedBio, Olema Oncology, Radius Therapeutics, and Roche

PFE

MT Newswires

15 days ago

Pfizer Finalizes $1.25 Billion Licensing Agreement for Cancer Drug With 3SBio

Pfizer Completes Licensing Agreement with 3SBio
PFE

Business Wire

15 days ago

Pfizer Completes Licensing Agreement with 3SBio

Benign Breast Disease and Early Breast Cancer Market Analysis Report 2025-2035 | Key Emerging Trends That are Reshaping the Landscape of Diagnosis, Treatment, and Patient Care
PFE

GlobeNewswire

15 days ago

Benign Breast Disease and Early Breast Cancer Market Analysis Report 2025-2035 | Key Emerging Trends That are Reshaping the Landscape of Diagnosis, Treatment, and Patient Care

Biosimilars Markets Global Forecast Report 2025-2035 | Launch of Glp-1 Biosimilars, Increasing Strategic Partnerships and Collaborations, & Growing Focus on Advanced R&D Fueling Opportunities
PFE

GlobeNewswire

15 days ago

Biosimilars Markets Global Forecast Report 2025-2035 | Launch of Glp-1 Biosimilars, Increasing Strategic Partnerships and Collaborations, & Growing Focus on Advanced R&D Fueling Opportunities

Abivax Hits The Stratosphere, Up Nearly 600%, On 'Potentially Disruptive' Results
PFE

Investor's Business Daily

16 days ago

Abivax Hits The Stratosphere, Up Nearly 600%, On 'Potentially Disruptive' Results

Africa Pharmaceuticals Market Analysis, Growth Trends, and Forecast Report 2025-2032 | Urbanization and NCDs Drive Demand, Regulatory Harmonization & Local Production Boost Growth
PFE

GlobeNewswire

16 days ago

Africa Pharmaceuticals Market Analysis, Growth Trends, and Forecast Report 2025-2032 | Urbanization and NCDs Drive Demand, Regulatory Harmonization & Local Production Boost Growth

Share on Social Networks: